Until Labs
PrivateLast Round
Series A
Sep 22, 2025
Total Funding Raised
$106M
Momentum Score
50 /100
Company Overview
Until Labs is a biotechnology company that develops perfusion hardware, cryoprotective agents, and rewarming infrastructure for organ-scale reversible cryopreservation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Until Labs Comps
Public and private peers based on sector, stage, and business model.
Until Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2025 | ||||
| Seed | Jun 10, 2024 |
Until Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Field Ventures | Series A |
| Founders Fund | Series A |
| Lux Capital | Series A |
Until Labs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Until Labs's valuation, stock price, and market status.
